Publication: A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)
No Thumbnail Available
Date
2006-10
Authors
Gürel, S.
Authors
Yurdaydın, Cihan
Wedemeyer, Heiner
Dalekos, George
Erhardt, Alexander
Çakaloğlu, Y.
Değertekin, H.
Zeuzem, Stefan
Zachou, Kalliopi
Bozkaya, Hakan
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Bu çalışma, 27-31 Ekim 2006 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 57. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
Keywords
Gastroenterology & hepatology
Citation
Yurdaydın, C. vd. (2006). ''A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)''. Hepatology, 44(4), Suplement 1, 230A-230A.